 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||| Liztox (botulinum toxin type A) / Huons
Enrollment closed, Trial primary completion date: To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy (clinicaltrials.gov) - Sep 26, 2024
P3, N=188, Active, not recruiting, Sponsor: Huons Biopharma
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2024 --> Mar 2024
- ||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap, Liztox (botulinum toxin type A) / Huons
Clinical, P3 data, Journal: A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox versus Botox in Post-Stroke Upper Limb Spasticity. (Pubmed Central) - Dec 26, 2023
No safety-related concerns were reported during the study. In conclusion, Liztox injection proved to be a secure and efficacious intervention for managing upper extremity spasticity in post-stroke patients.
- ||||| Liztox (botulinum toxin type A) / Huons
Trial completion: To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb (clinicaltrials.gov) - Aug 1, 2023
P3, N=198, Completed, Sponsor: Huons Co., Ltd.
In conclusion, Liztox injection proved to be a secure and efficacious intervention for managing upper extremity spasticity in post-stroke patients. Recruiting --> Completed
- | Liztox (botulinum toxin type A) / Huons
New P3 trial: To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy (clinicaltrials.gov) - Jul 27, 2023
P3, N=168, Recruiting, Sponsor: Huons Biopharma
- |||||||| Liztox (botulinum toxin type A) / Huons
New P3 trial: To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb (clinicaltrials.gov) - Mar 21, 2022
P3, N=198, Recruiting, Sponsor: Huons Co., Ltd.
- || Liztox (botulinum toxin type A) / Huons
New P1 trial: A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity (clinicaltrials.gov) - Jun 3, 2020
P1, N=13, Enrolling by invitation, Sponsor: Huons Co., Ltd.
- | Liztox (botulinum toxin type A) / Huons
New P3 trial: A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox (clinicaltrials.gov) - Sep 9, 2019
P3, N=290, Recruiting, Sponsor: Huons Co., Ltd.
- |||| Liztox (botulinum toxin type A) / Huons
Trial completion: The Safety and Efficacy Study of HU-014 Versus Botox (clinicaltrials.gov) - Apr 12, 2018
P1/2, N=57, Completed, Sponsor: Huons Co.,Ltd.
Recruiting --> Completed Recruiting --> Completed
- ||||| Liztox (botulinum toxin type A) / Huons
New P1/2 trial: The Safety and Efficacy Study of HU-014 Versus Botox (clinicaltrials.gov) - Nov 13, 2016
P1/2, N=60, Recruiting, Sponsor: Huons Co.,Ltd.